{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:40:24Z","timestamp":1791261624433,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["22377001"],"award-info":[{"award-number":["22377001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002947","name":"Anhui Medical University","doi-asserted-by":"publisher","award":["2023xktdyxa2"],"award-info":[{"award-number":["2023xktdyxa2"]}],"id":[{"id":"10.13039\/501100002947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.bioorg.2025.109297","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:06:32Z","timestamp":1764201992000},"page":"109297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Design and synthesis of a 1,3,6-trimethyl-1H-benzo[d]imidazole-5-sulfonamide derivative as a type I CDK8 inhibitor against colorectal cancer"],"prefix":"10.1016","volume":"168","author":[{"given":"Juncheng","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daxing","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cui","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2025.109297_bb0005","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","article-title":"Mechanisms of metastatic colorectal cancer","volume":"21","author":"Canellas-Socias","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bioorg.2025.109297_bb0010","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"},{"issue":"2018","key":"10.1016\/j.bioorg.2025.109297_bb0015","first-page":"394","article-title":"GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bioorg.2025.109297_bb0020","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12943-022-01616-7","article-title":"Wnt signaling in colorectal cancer: pathogenic role and therapeutic target","volume":"21","author":"Zhao","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bioorg.2025.109297_bb0025","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/s41467-022-28286-9","article-title":"Galphai2-induced conductin\/axin2 condensates inhibit Wnt\/beta-catenin signaling and suppress cancer growth","volume":"13","author":"Miete","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109297_bb0030","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41467-021-27602-z","article-title":"Constitutive activation of canonical Wnt signaling disrupts choroid plexus epithelial fate","volume":"13","author":"Parichha","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109297_bb0035","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/path.5868","article-title":"Characterization of RNF43 frameshift mutations that drive Wnt ligand- and R-spondin-dependent colon cancer","volume":"257","author":"Yamamoto","year":"2022","journal-title":"J. Pathol."},{"key":"10.1016\/j.bioorg.2025.109297_bb0040","doi-asserted-by":"crossref","DOI":"10.1242\/dev.146589","article-title":"Wnt signaling in development and tissue homeostasis","volume":"145","author":"Steinhart","year":"2018","journal-title":"Development"},{"key":"10.1016\/j.bioorg.2025.109297_bb0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s13045-020-00990-3","article-title":"Targeting the Wnt\/beta-catenin signaling pathway in cancer","volume":"13","author":"Zhang","year":"2020","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bioorg.2025.109297_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cells10071792","article-title":"Unveiling the roles of low-density lipoprotein receptor-related protein 6 in intestinal homeostasis, regeneration and oncogenesis","volume":"10","author":"Raisch","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2025.109297_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.bioorg.2025.109297_bb0060","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature07179","article-title":"CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity","volume":"455","author":"Firestein","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.109297_bb0065","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejmech.2018.11.076","article-title":"CDK8 as a therapeutic target for cancers and recent developments in discovery of CDK8 inhibitors","volume":"164","author":"Xi","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109297_bb0070","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1038\/onc.2012.364","article-title":"CDK8 regulates E2F1 transcriptional activity through S375 phosphorylation","volume":"32","author":"Zhao","year":"2013","journal-title":"Oncogene"},{"key":"10.1016\/j.bioorg.2025.109297_bb0075","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nature07310","article-title":"E2F1 represses beta-catenin transcription and is antagonized by both pRB and CDK8","volume":"455","author":"Morris","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.109297_bb0080","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.molcel.2004.10.014","article-title":"Mastermind recruits CycC:CDK8 to phosphorylate the notch ICD and coordinate activation with turnover","volume":"16","author":"Fryer","year":"2004","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2025.109297_bb0085","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.96465","article-title":"Knockout of cyclin-dependent kinases 8 and 19 leads to depletion of cyclin C and suppresses spermatogenesis and male fertility in mice","volume":"13","author":"Bruter","year":"2025","journal-title":"Elife"},{"key":"10.1016\/j.bioorg.2025.109297_bb0090","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1016\/j.molcel.2024.09.001","article-title":"Structural basis of the human transcriptional mediator regulated by its dissociable kinase module","volume":"84","author":"Chao","year":"2024","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bioorg.2025.109297_bb0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1101\/gad.1767009","article-title":"The human CDK8 subcomplex is a molecular switch that controls mediator coactivator function","volume":"23","author":"Knuesel","year":"2009","journal-title":"Genes Dev."},{"key":"10.1016\/j.bioorg.2025.109297_bb0100","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/10409238.2013.840259","article-title":"The mediator complex and transcription regulation","volume":"48","author":"Poss","year":"2013","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.109297_bb0105","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/nrm3951","article-title":"The mediator complex: a central integrator of transcription","volume":"16","author":"Allen","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bioorg.2025.109297_bb0110","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1038\/s41467-025-59014-8","article-title":"Structural basis of human mediator recruitment by the phosphorylated transcription factor Elk-1","volume":"16","author":"Monte","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioorg.2025.109297_bb0115","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1002\/ijc.24908","article-title":"CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival","volume":"126","author":"Firestein","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bioorg.2025.109297_bb0120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s12967-023-03933-x","article-title":"Loss of miR-26b-5p promotes gastric cancer progression via miR-26b-5p-PDE4B\/CDK8-STAT3 feedback loop","volume":"21","author":"Xu","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.bioorg.2025.109297_bb0125","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/nature09590","article-title":"The histone variant macroH2A suppresses melanoma progression through regulation of CDK8","volume":"468","author":"Kapoor","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bioorg.2025.109297_bb0130","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.1021\/acs.jmedchem.2c01718","article-title":"Discovery of potent, selective, and orally bioavailable small-molecule inhibitors of CDK8 for the treatment of Cancer","volume":"66","author":"Li","year":"2023","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109297_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.113043","article-title":"Angel or devil\u202f? - CDK8 as the new drug target","volume":"213","author":"Wu","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109297_bb0140","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.tox.2013.07.013","article-title":"Wogonin induced G1 cell cycle arrest by regulating Wnt\/beta-catenin signaling pathway and inactivating CDK8 in human colorectal cancer carcinoma cells","volume":"312","author":"He","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.bioorg.2025.109297_bb0145","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1016\/j.apsb.2024.03.024","article-title":"Suppressing Wnt signaling of the blood\u2013tumor barrier to intensify drug delivery and inhibit lipogenesis of brain metastases","volume":"14","author":"Tong","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioorg.2025.109297_bb0150","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/nchembio.1952","article-title":"A selective chemical probe for exploring the role of CDK8 and CDK19 in human disease","volume":"11","author":"Dale","year":"2015","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bioorg.2025.109297_bb0155","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.celrep.2017.10.058","article-title":"CDK8 kinase activity promotes glycolysis","volume":"21","author":"Galbraith","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioorg.2025.109297_bb0160","doi-asserted-by":"crossref","first-page":"9337","DOI":"10.1021\/acs.jmedchem.6b00597","article-title":"Structure-based optimization of potent, selective, and orally bioavailable CDK8 inhibitors discovered by high-throughput screening","volume":"59","author":"Czodrowski","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109297_bb0165","doi-asserted-by":"crossref","DOI":"10.3390\/cells8111413","article-title":"Systemic toxicity reported for CDK8\/19 inhibitors CCT251921 and MSC2530818 is not due to target inhibition","volume":"8","author":"Chen","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.bioorg.2025.109297_bb0170","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jmb.2011.07.020","article-title":"The structure of CDK8\/CycC implicates specificity in the CDK\/cyclin family and reveals interaction with a deep pocket binder","volume":"412","author":"Schneider","year":"2011","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bioorg.2025.109297_bb0175","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1158\/0008-5472.CAN-04-1443","article-title":"BAY 43-9006 exhibits broad Spectrum Oral antitumor activity and targets the RAF\/MEK\/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis","volume":"64","author":"Wilhelm","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.bioorg.2025.109297_bb0180","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1021\/jm100395q","volume":"53","author":"Huang","year":"2010","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109297_bb0185","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1158\/1535-7163.MCT-05-0410","article-title":"Preclinical activity of ABT-869, a multitargeted receptor tyrosine kinase inhibitor","volume":"5","author":"Albert","year":"2006","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bioorg.2025.109297_bb0190","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1021\/acsmedchemlett.6b00044","article-title":"Design and development of a series of potent and selective type II inhibitors of CDK8","volume":"7","author":"Bergeron","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2025.109297_bb0195","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1073\/pnas.1917635117","article-title":"A precisely positioned MED12 activation helix stimulates CDK8 kinase activity","volume":"117","author":"Klatt","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bioorg.2025.109297_bb0200","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1021\/jm501436m","article-title":"Discovery of potent, orally bioavailable, small-molecule inhibitors of WNT Signaling from a cell-based pathway screen","volume":"58","author":"Mallinger","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2025.109297_bb0205","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25061428","article-title":"Nucleophilic substitution at tetracoordinate Sulfur. Kinetics and mechanism of the chloride-chloride exchange reaction in Arenesulfonyl chlorides: counterintuitive acceleration of substitution at sulfonyl Sulfur by ortho-alkyl groups and its origin","volume":"25","author":"Mikolajczyk","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2025.109297_bb0210","doi-asserted-by":"crossref","first-page":"9627","DOI":"10.1021\/jo8016428","article-title":"The endocyclic restriction test: the geometries of nucleophilic substitutions at Sulfur(VI) and Sulfur(II)","volume":"73","author":"Jarboe","year":"2008","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.bioorg.2025.109297_bb0215","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.immuni.2012.10.017","article-title":"CDK8 kinase phosphorylates transcription factor STAT1 to selectively regulate the interferon response","volume":"38","author":"Bancerek","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.bioorg.2025.109297_bb0220","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/beta-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.109297_bb0225","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41392-021-00701-5","article-title":"Wnt\/beta-catenin signaling in cancers and targeted therapies","volume":"6","author":"Yu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bioorg.2025.109297_bb0230","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41568-022-00456-3","article-title":"Targeting CDK4 and CDK6 in cancer","volume":"22","author":"Goel","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bioorg.2025.109297_bb0235","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ccell.2021.03.010","article-title":"Targeting cell-cycle machinery in cancer","volume":"39","author":"Suski","year":"2021","journal-title":"Cancer Cell"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206825011770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T14:57:59Z","timestamp":1768402679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206825011770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":47,"alternative-id":["S0045206825011770"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109297","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Design and synthesis of a 1,3,6-trimethyl-1H-benzo[d]imidazole-5-sulfonamide derivative as a type I CDK8 inhibitor against colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2025.109297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109297"}}